Safe and Effective Rezūm Therapy for Benign Prostatic Hyperplasia

Rezūm water vapour therapy is a safe and effective new BPH treatment that can offer longer term relief from symptoms without the risks and discomfort of surgery.

What is Benign Prostatic Hyperplasia?

Benign prostatic hyperplasia (BPH), also called prostate gland enlargements, is a condition that affects mostly middle-aged men. The most common symptoms are difficulty in fully emptying the bladder, a frequent and urgent need to urinate, and nocturia (a condition that causes the sufferer to wake up during the night to urinate.

Although usually not a serious threat to health, it can negatively affect the patient’s quality life. Left untreated, it could also lead to complications such as urinary tract infection (UTI) or acute urinary retention (the sudden inability to pass any urine).

Cause of BPH

The cause of prostate enlargement is unknown, but it’s believed to be linked to hormonal changes as a man gets older. The balance of hormones in the body changes as a man gets older, and this may cause the prostate gland to grow.

What Treatments Are Available For BPH?

Treatment for an enlarged prostate will depend on how severe the symptoms are. The most common treatments of this pathology include pharmacologic and invasive interventions (surgeries), both of which vary in effectiveness and come with a myriad of side effects. Recent advancements have allowed for the development of Rezūm, a minimally invasive and effective approach to treating BPH while maintaining a good safety profile.

Safe and Effective Rezūm Water Vapour Therapy

Rezūm technology uses heat from radiofrequency-generated water vapour to ablate prostate tissue. The therapy is a minimally invasive treatment for an enlarged prostate that uses controlled doses of hot steam to directly evaporate and reduce portions of the swollen prostate that are causing obstruction of the urethra.

Rezūm has undergone rigorous studies and is recommended by the Canadian Urological Association as a minimally invasive BPH symptom reduction method for men interested in preserving erectile and ejaculatory function. It was also approved by the US FDA in 2015 for the treatment of the enlarged prostate.

SanoMed is the first clinic to offer Rezūm in Quebec and Eastern Canada.

Conclusion

Rezūm is a safe and effective therapy for treating patients with benign prostatic hyperplasia (BPH). As a minimally invasive therapy, it is an excellent option for patients, particularly those who are looking for non-surgical and non pharmacologic solutions to this common condition affecting middle-aged men.